14.54

1.36% -0.20

After Hours: 14.51 -0.03 -0.21%

Adma Biologics Inc (ADMA)

Overview News Price History Option Chain Financials Discussions Forecast

Adma Biologics Inc stock is traded at $14.54, with a volume of 3.45M. It is down -1.36% in the last 24 hours and down -7.74% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Previous Close:

$14.74

Open:

$14.78

24h Volume:

3.45M

Relative Volume:

1.09

Market Cap:

$3.47B

Revenue:

$426.45M

Net Income/Loss:

$197.67M

P/E Ratio:

17.73

EPS:

0.82

Net Cash Flow:

$110.10M

1W Performance:

-0.82%

1M Performance:

-7.74%

6M Performance:

-22.16%

1Y Performance:

-14.52%

1-Day Range:

$14.28

$14.78

1-Week Range:

$13.82

$14.82

52-Week Range:

$13.82

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name

Adma Biologics Inc

Sector

Healthcare (1141)

Industry

Biotechnology (637)

Phone

(201) 478-5552

Address

C/O ADMA BIOLOGICS, INC., RAMSEY

Employee

685

Twitter

@AdmaBiologics

Next Earnings Date

2025-03-03

Latest SEC Filings

ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADMA Adma Biologics Inc	14.54	3.52B	426.45M	197.67M	110.10M	0.82
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-19-23	Resumed	Raymond James	Strong Buy
Oct-13-22	Initiated	Mizuho	Buy
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight
Jun-04-19	Initiated	Jefferies	Buy
Apr-15-19	Reiterated	H.C. Wainwright	Buy
Feb-07-19	Resumed	H.C. Wainwright	Buy
Dec-11-17	Reiterated	Maxim Group	Buy
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy
May-13-15	Reiterated	Maxim Group	Buy
Dec-08-14	Initiated	Oppenheimer	Outperform
Dec-01-14	Reiterated	Maxim Group	Buy

View All

Adma Biologics Inc Stock (ADMA) Latest News

Oct 12, 2025

Can momentum traders help lift ADMA Biologics Inc.Trade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com

Oct 12, 2025

Oct 10, 2025

Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know - Nasdaq

Oct 10, 2025

Using data filters to optimize entry into ADMA Biologics Inc.Weekly Profit Recap & High Win Rate Trade Tips - newser.com

Oct 10, 2025

What momentum shifts mean for ADMA Biologics Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025

What moving averages say about ADMA Biologics Inc.2025 Retail Activity & Safe Entry Point Alerts - newser.com

Oct 10, 2025

Is ADMA Biologics Inc. stock oversold or undervaluedMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com

Oct 10, 2025

Volume spikes in ADMA Biologics Inc. stock – what they mean2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com

Oct 10, 2025

Using flow based indicators on ADMA Biologics Inc.Trade Volume Report & Weekly High Potential Stock Alerts - newser.com

Oct 10, 2025

Oct 08, 2025

Weiss Ratings Reaffirms Buy (B-) Rating for ADMA Biologics (NASDAQ:ADMA) - MarketBeat

Oct 08, 2025

Oct 06, 2025

Can ADMA Biologics Inc. stock beat market expectations this quarter2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com

Oct 06, 2025

Oct 05, 2025

Should you wait for a breakout in ADMA Biologics Inc.Rate Hike & Verified Chart Pattern Signals - newser.com

Oct 05, 2025

What MACD and RSI say about ADMA Biologics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com

Oct 05, 2025

Is ADMA Biologics Inc. stock trading near support levels2025 Big Picture & Real-Time Stock Entry Alerts - newser.com

Oct 05, 2025

Tick level data insight on ADMA Biologics Inc. volatilityJuly 2025 Outlook & Consistent Profit Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

1,800,440 Shares in ADMA Biologics Inc $ADMA Bought by Vaughan Nelson Investment Management L.P. - MarketBeat

Oct 04, 2025

Oct 03, 2025

Evaluating ADMA Biologics Inc. with trendline analysisQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com

Oct 03, 2025

Oct 01, 2025

Why Adma Biologics (ADMA) Outpaced the Stock Market Today - sharewise.com

Oct 01, 2025

Sep 30, 2025

What analysts say about ADMA Biologics Inc stockRisk Mitigation Techniques & Analyze Your Portfolio Risk in Seconds - earlytimes.in

Sep 30, 2025

Sep 29, 2025

ADMA Biologics (NASDAQ:ADMA) Stock Price Down 5.1%Here's Why - MarketBeat

Sep 29, 2025